MDY Mdy Healthcare

RNS Number:0525X
Medisys PLC
11 January 2001

                                
                           Medisys PLC
                   ("Medisys" or "the Group")

      Medisys selects McKessonHBOC as Distribution Partner
                    for Futura Safety Syringe
                                
                                
Medisys  is  pleased to announce the appointment of  McKessonHBOC
("McKesson")  as its distribution partner for the  Futura  safety
syringe in the United States.  This is a further significant step
in  the  Group's  plans for the US market launch  of  the  Futura
syringe  and  its  objective  of ensuring  that  the  product  is
available   through  the  largest  medical  product  distribution
network in North America.

McKesson  is  the  largest  distributor  of  pharmaceuticals  and
medical  supplies in the United States. The company has unmatched
depth,  breadth and reach, delivering unique cost  reduction  and
quality improvement solutions to:

  *    25,000 independent and chain pharmacies;
  *    5,000 hospitals and integrated delivery networks;
  *    35,000 physician practices encompassing more than 250,0000
       individual physicians;
  *    10,000 extended care sites; and,
  *   600 payor organizations.

The company reported revenues of US$36.7 billion for fiscal 2000.

Futura  Medical  and McKesson envisage the Futura safety  syringe
becoming  a  cornerstone  product in a  comprehensive  Healthcare
Worker  Safety Product Program.  The Futura/McKesson  partnership
will enable healthcare providers to comply with state and federal
legislation  requiring the use of safety products,  such  as  the
Futura  syringe, which are designed to protect healthcare workers
from injuries associated with traditional sharps devices.

The  Futura  safety  syringe  is  an  innovative  safety  syringe
featuring   an   elastomer  based  retraction   function,   which
automatically  and  passively  retracts  the  needle  upon   full
delivery  of medication, thereby reducing the risk of needlestick
injury.  The  Needlestick Safety and Prevention Act, signed  into
law  in  November 2000, requires all US healthcare  providers  to
evaluate  and  use medical devices with engineered sharps  injury
protection.    The  legislation  is  expected  to   significantly
increase demand for safety devices.  The Futura safety syringe is
due for market launch in the US during the first half of 2001.

David  Wong, Medisys Chief Executive Officer, commented: "We  are
delighted  to  have  our Futura safety syringe  as  part  of  the
Healthcare  Worker Safety Product Program and we look forward  to
working with McKesson as we launch the product.  This partnership
between  Futura and McKesson will enable healthcare providers  in
the  United  States to meet the requirements of  the  legislative
initiatives  in  the  most  cost  effective  way  with  the  best
available technologies and we are convinced that it will help  us
to achieve maximum market penetration for the Futura syringe."

Kevin  Swann,  President, McKessonHBOC Medical  Group  explained,
"The Healthcare Worker Safety Product Program will offer products
using  innovative  safety technology covering  a  wide  range  of
applications  including  hypodermic, blood  collection,  infusion
products, vein access and surgical procedures. Not only will  the
program  provide  for the products, but will include  value-added
programs  of  education, conversion management, public  relations
and clinical support as well as compliance."

McKessonHBOC, a Fortune 40 company, is the world's largest supply
management  and healthcare information technology  company.  More
information about McKessonHBOC is available at www.mckhboc.com.

Enquiries:

Medisys  PLC                                  020 7563 5200
Michael Barry, Chief Financial Officer

Square  Mile  BSMG                            020 7601 1000
Kevin Smith/Becky Jewers

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024